Background-The relationship between left ventricular (LV) contractile functional reserve and gene expression ofCa 2ϩ -handling proteins in patients with hypertrophic cardiomyopathy (HCM) remains to be clarified. Methods and Results-We calculated the maximum first derivative of LV pressure (LV dP/dt max ) and the LV pressure half-time (T 1/2 ) during pacing in 14 patients with nonobstructive HCM (LV ejection fraction Ͼ55%) and 7 control subjects. Endomyocardial tissue was obtained, and mRNA levels of sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA2), ryanodine receptor-2, phospholamban, calsequestrin, and Na ϩ /Ca 2ϩ exchanger were quantified by use of a real-time quantitative reverse transcription-polymerase chain reaction method. Group A consisted of 7 HCM patients who showed a progressive rise in the LV dP/dt max with increased heart rate. Group B consisted of 7 HCM patients in whom the heart rate-LV dP/dt max relation was biphasic at physiological pacing rates. Both the mean maximal wall thickness and the LV hypertrophy score in group B were greater than in group A (20Ϯ5 versus 15Ϯ3 mm and 7Ϯ1 versus 5Ϯ2 points, respectively). SERCA2 mRNA levels were significantly lower in group B (SERCA2/GAPDH ratio 0.34Ϯ0.15) compared with group A (0.72Ϯ0.27) and control subjects (0.85Ϯ0.47), whereas the mRNA expression of ryanodine receptor-2, phospholamban, calsequestrin, and Na ϩ /Ca 2ϩ exchanger were similar in all groups. Conclusions-These results suggest that downregulation of SERCA2 mRNA, resulting in altered Ca 2ϩ handling, may contribute to impaired LV contractile reserve in HCM patients with severe hypertrophy, even in the absence of detectable baseline systolic dysfunction. (Circulation. 2001;104:658-663.)